Retromer Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Retromer Therapeutics General Information

Description

Developer of a new class of therapeutics designed to restore endolysosomal function in neurodegenerative diseases. The company offers innovative strategies to stabilize the retromer complex, enhance protein transport, and improve neuronal health, enabling patients with conditions like Alzheimer's and Parkinson's to potentially experience disease modification and improved quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 East 33rd Street
  • Apartment 14M
  • New York, NY 10016
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 300 East 33rd Street
  • Apartment 14M
  • New York, NY 10016
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Retromer Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Sep-2024 Completed Generating Revenue
1. Corporate 01-Jan-2020 Completed Generating Revenue
To view Retromer Therapeutics’s complete valuation and funding history, request access »

Retromer Therapeutics Patents

Retromer Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024178386-A1 Methods of treating endosomal trafficking diseases Inactive 24-Feb-2023
WO-2024129696-A1 Aav and lentiviral constructs comprising a sorl1 mini-gene for use in treating neurodegenerative diseases Inactive 12-Dec-2022

Retromer Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crom Capital Management Hedge Fund Minority
CinRx Pharma VC-Backed Company Minority
To view Retromer Therapeutics’s complete investors history, request access »

Retromer Therapeutics FAQs

  • When was Retromer Therapeutics founded?

    Retromer Therapeutics was founded in 2020.

  • Where is Retromer Therapeutics headquartered?

    Retromer Therapeutics is headquartered in New York, NY.

  • What industry is Retromer Therapeutics in?

    Retromer Therapeutics’s primary industry is Drug Discovery.

  • Is Retromer Therapeutics a private or public company?

    Retromer Therapeutics is a Private company.

  • What is Retromer Therapeutics’s current revenue?

    The current revenue for Retromer Therapeutics is .

  • Who are Retromer Therapeutics’s investors?

    Crom Capital Management and CinRx Pharma have invested in Retromer Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process